| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_244630447017dc0b8a917a82d7ad0036 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557 |
| filingDate |
2004-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93a8298edee671c981125107d43fe2d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b3b8bffa4c300434d974ba2e620e5a0 |
| publicationDate |
2010-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7790362-B2 |
| titleOfInvention |
Controlled platelet activation to monitor therapy of ADP antagonists |
| abstract |
A method is provided of determining whether an individual has reduced ability to form platelet thrombi. An ADP platelet activator and one or platelet inhibitors are provided. At least one of the platelet inhibitors is Prostaglandin E1 (PGE1). An alternate signal transduction pathway is produced. A final concentration of ADP is 2 to 35 μM and a final concentration of PGE1 is 2 to 30 nM, preferably 20 to 25 nM. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9506938-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10746750-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10215767-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010184084-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8574828-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11131680-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008299587-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011065125-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014200240-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015065986-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9404933-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11061038-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11360106-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9851367-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9915671-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9341637-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10996230-B2 |
| priorityDate |
2003-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |